Foyston, Gordon, & Payne Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$17.3M |
| 2 |
Sabre
SABR
|
+$5.72M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$5.1M |
| 4 |
Motorola Solutions
MSI
|
+$3.44M |
| 5 |
TotalEnergies
TTE
|
+$3.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Compañía de Cervecerías Unidas
CCU
|
+$4.44M |
| 2 |
M&T Bank
MTB
|
+$3.7M |
| 3 |
TUP
Tupperware Brands Corporation
TUP
|
+$3.56M |
| 4 |
PTR
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
|
+$3.5M |
| 5 |
Amdocs
DOX
|
+$3.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.37% |
| 2 | Technology | 17.1% |
| 3 | Industrials | 13.82% |
| 4 | Financials | 11.31% |
| 5 | Consumer Staples | 9.58% |
Similar funds
Foyston, Gordon, & Payne's Q1 2017 Portfolio in Review
As of Q1 2017, Foyston, Gordon, & Payne held 73 positions worth $464M, up 10% from $421M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Foyston, Gordon, & Payne deployed $17.6M of net new capital in Q1 2017, opening 2 new positions and adding to 31 existing holdings. Its largest new stake was Sabre: 249,809 shares worth $5.29M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Compañía de Cervecerías Unidas, an estimated $4.44M trimmed.
- Foyston, Gordon, & Payne's largest Q1 2017 buy was Sabre: 249,809 shares worth $5.29M.
- Foyston, Gordon, & Payne added most to Medtronic in Q1 2017, an estimated $17.3M increase.
- Foyston, Gordon, & Payne's biggest Q1 2017 reduction was Compañía de Cervecerías Unidas, cutting an estimated $4.44M.
- Foyston, Gordon, & Payne fully exited M&T Bank in Q1 2017, selling an estimated $3.7M.
- Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $464M portfolio in Q1 2017.
- Foyston, Gordon, & Payne opened 2 new positions and closed 4 in Q1 2017.
- Foyston, Gordon, & Payne's portfolio value rose 10% quarter-over-quarter to $464M.
Based on Foyston, Gordon, & Payne's 13F filing for Q1 2017, filed 12 May 2017.